MIRA Pharmaceuticals

MIRA · NASDAQ

$0.6501+$0.008 (+1.25%)TodayMarket closed · Oct 20, 4:46 PM ET

Prev close $0.6421

Latest news

NewsSep 21, 5:06 PM ET
12 Health Care Stocks Moving In Monday's After-Market Session
Press releaseSep 17, 8:30 AM ETGlobe Newswire
MIRA Pharmaceuticals Advances Ketamir-2 to Phase 2a in Chemotherapy-Induced Peripheral Neuropathy (CIPN) Following FDA Review
NewsSep 1, 1:12 PM ETVandana Singh
Why Is MIRA Pharmaceuticals Stock Gaining Tuesday?
NewsSep 1, 1:07 PM ET
12 Health Care Stocks Moving In Tuesday's Intraday Session
Press releaseSep 1, 8:00 AM ETGlobe Newswire
MIRA Pharmaceuticals Advances Non-Opioid Oral MIRA-55 for Inflammatory Pain Toward IND
Press releaseAug 6, 8:00 AM ETGlobe Newswire
MIRA Reports Positive 7-Day Dog Study Results for SKNY-1
NewsAug 3, 5:05 PM ET
12 Health Care Stocks Moving In Monday's After-Market Session
Press releaseJul 30, 8:00 AM ETGlobe Newswire
MIRA Pharmaceuticals Progresses MIRA-55 and SKNY-1 Toward IND-Enabling Studies
Press releaseJul 10, 8:00 AM ETACCESS Newswire
MIRA Pharmaceuticals Reports Successful Formulation Results Supporting Development of MIRA-55 as a Non-Opioid Oral Therapy for Chronic Inflammatory Pain
Press releaseJul 6, 9:00 AM ETACCESS Newswire
MIRA Pharmaceuticals Reports Successful Formulation Results for SKNY-1, Its Oral Drug Candidate for Obesity and Addiction
Press releaseJun 25, 8:15 AM ETACCESS Newswire
MIRA Pharmaceuticals Reports New Preclinical Data Demonstrating Mira-55's Differentiated Mechanism of Action and Anxiolytic Activity Relative to THC
Press releaseJun 17, 8:00 AM ETACCESS Newswire
MIRA Pharmaceuticals Submits Phase 2a Clinical Trial Protocol to FDA for Ketamir-2 in Chemotherapy-Induced Peripheral Neuropathy
Press releaseJun 4, 8:00 AM ETACCESS Newswire
MIRA Pharmaceuticals Secures Worldwide Exclusive Rights to MIRA-55 and SKNY-1
NewsMar 24, 8:05 AM ET
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
NewsMar 23, 1:05 PM ET
12 Health Care Stocks Moving In Monday's Intraday Session
NewsNov 10, 4:07 PM ET
12 Health Care Stocks Moving In Monday's After-Market Session
NewsOct 16, 2:16 PM ETEvette Mitkov
MIRA Pharmaceuticals Stock Surges Following Positive Preclinical Data
NewsOct 16, 1:08 PM ET
12 Health Care Stocks Moving In Thursday's Intraday Session
NewsOct 16, 12:31 PM ETAvi Kapoor
Dow Dips Over 100 Points; US Crude Oil Inventories Surge
NewsOct 16, 10:00 AM ETAvi Kapoor
Dow Surges Over 100 Points; Charles Schwab Posts Upbeat Earnings
NewsOct 16, 7:14 AM ET
Market-Moving News for October 16th
NewsOct 16, 1:15 AM ETMohd Haider
Why Mira Pharmaceuticals Shares Rose 69% After Hours?
NewsJul 3, 6:00 AM ETRishabh Mishra
US Stocks Likely To Open Higher As Trump Announces Vietnam Trade Deal: S&P 500's Golden Cross 'Reason To Expect Better Than Average Returns,' Says Expert
NewsJul 3, 1:46 AM ETMohd Haider
MIRA Pharmaceuticals' Marijuana Analog Mira-55 Shows Potent Pain Relief In Preclinical Study, Stock Jumps 50% After Hours
NewsJun 18, 11:07 AM ET
Watching MIRA Pharmaceuticals; Zacks Small-Cap Research Gives Stock $17.75 Valuation
NewsMay 15, 12:08 PM ET
Watching MIRA Pharmaceuticals; Zacks Small-Cap Research Gives Stock $17.75 Price Valuation
NewsMay 8, 8:07 AM ET
12 Health Care Stocks Moving In Thursday's Pre-Market Session
NewsApr 17, 1:05 PM ET
12 Health Care Stocks Moving In Thursday's Intraday Session
NewsApr 16, 1:06 PM ET
12 Health Care Stocks Moving In Wednesday's Intraday Session
NewsMar 13, 12:27 PM ET
Watching MIRA Pharmaceuticals; Zacks Small-Cap Research Gives Stock $17.75 Price Valuation
NewsNov 13, 11:58 AM ET
Watching MIRA Pharmaceuticals; Zacks Small-Cap Research Sets $17.75 Price Valuation On Stock
NewsOct 28, 8:07 AM ET
12 Health Care Stocks Moving In Monday's Pre-Market Session
NewsAug 26, 11:03 AM ET
Watching MIRA Pharmaceuticals; Zacks Small-Cap Research Gives Stock $16.50 Price Valuation
NewsAug 26, 5:58 AM ETAvi Kapoor
Why MIRA Pharmaceuticals Shares Are Trading Higher By Around 45%; Here Are 20 Stocks Moving Premarket
NewsAug 14, 12:04 PM ET
Watching MIRA Pharmaceuticals; Shares See Volume After Zacks Small-Cap Research Gives Stock $16.50 Price Valuation
NewsAug 1, 6:55 PM ETChris Katje
EXCLUSIVE: Top 20 Most-Searched Tickers On Benzinga Pro In July 2024 – Where Do Tesla, Nvidia, Apple, CrowdStrike Rank?
NewsJul 25, 3:24 PM ETVandana Singh
Mental Health Disorders-Focused MIRA Pharmaceuticals Unveils Additional Preclinical Data
NewsJul 23, 1:21 PM ETAvi Kapoor
Why Comcast Shares Are Trading Lower By 6%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.

Latest news

12 Health Care Stocks Moving In Monday's After-Market Session

MIRA Pharmaceuticals Advances Ketamir-2 to Phase 2a in Chemotherapy-Induced Peripheral Neuropathy (CIPN) Following FDA Review

Why Is MIRA Pharmaceuticals Stock Gaining Tuesday?

12 Health Care Stocks Moving In Tuesday's Intraday Session

MIRA Pharmaceuticals Advances Non-Opioid Oral MIRA-55 for Inflammatory Pain Toward IND

MIRA Reports Positive 7-Day Dog Study Results for SKNY-1

12 Health Care Stocks Moving In Monday's After-Market Session

MIRA Pharmaceuticals Progresses MIRA-55 and SKNY-1 Toward IND-Enabling Studies

MIRA Pharmaceuticals Reports Successful Formulation Results Supporting Development of MIRA-55 as a Non-Opioid Oral Therapy for Chronic Inflammatory Pain

MIRA Pharmaceuticals Reports Successful Formulation Results for SKNY-1, Its Oral Drug Candidate for Obesity and Addiction

MIRA Pharmaceuticals Reports New Preclinical Data Demonstrating Mira-55's Differentiated Mechanism of Action and Anxiolytic Activity Relative to THC

MIRA Pharmaceuticals Submits Phase 2a Clinical Trial Protocol to FDA for Ketamir-2 in Chemotherapy-Induced Peripheral Neuropathy

MIRA Pharmaceuticals Secures Worldwide Exclusive Rights to MIRA-55 and SKNY-1

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

12 Health Care Stocks Moving In Monday's Intraday Session

12 Health Care Stocks Moving In Monday's After-Market Session

MIRA Pharmaceuticals Stock Surges Following Positive Preclinical Data

12 Health Care Stocks Moving In Thursday's Intraday Session

Dow Dips Over 100 Points; US Crude Oil Inventories Surge

Dow Surges Over 100 Points; Charles Schwab Posts Upbeat Earnings

Market-Moving News for October 16th

Why Mira Pharmaceuticals Shares Rose 69% After Hours?

US Stocks Likely To Open Higher As Trump Announces Vietnam Trade Deal: S&P 500's Golden Cross 'Reason To Expect Better Than Average Returns,' Says Expert

MIRA Pharmaceuticals' Marijuana Analog Mira-55 Shows Potent Pain Relief In Preclinical Study, Stock Jumps 50% After Hours

Watching MIRA Pharmaceuticals; Zacks Small-Cap Research Gives Stock $17.75 Valuation

Watching MIRA Pharmaceuticals; Zacks Small-Cap Research Gives Stock $17.75 Price Valuation

12 Health Care Stocks Moving In Thursday's Pre-Market Session

12 Health Care Stocks Moving In Thursday's Intraday Session

12 Health Care Stocks Moving In Wednesday's Intraday Session

Watching MIRA Pharmaceuticals; Zacks Small-Cap Research Gives Stock $17.75 Price Valuation

Watching MIRA Pharmaceuticals; Zacks Small-Cap Research Sets $17.75 Price Valuation On Stock

12 Health Care Stocks Moving In Monday's Pre-Market Session

Watching MIRA Pharmaceuticals; Zacks Small-Cap Research Gives Stock $16.50 Price Valuation

Why MIRA Pharmaceuticals Shares Are Trading Higher By Around 45%; Here Are 20 Stocks Moving Premarket

Watching MIRA Pharmaceuticals; Shares See Volume After Zacks Small-Cap Research Gives Stock $16.50 Price Valuation

EXCLUSIVE: Top 20 Most-Searched Tickers On Benzinga Pro In July 2024 – Where Do Tesla, Nvidia, Apple, CrowdStrike Rank?

Mental Health Disorders-Focused MIRA Pharmaceuticals Unveils Additional Preclinical Data

Why Comcast Shares Are Trading Lower By 6%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session